Cargando…

Advances in Osteoporosis Therapy: Focus on Osteoanabolic Agents, Secondary Fracture Prevention, and Perioperative Bone Health

PURPOSE OF REVIEW: This review summarizes recently published data and other developments around osteoanabolic osteoporosis therapies in patients with very high fracture risk, including those undergoing bone-related surgery. RECENT FINDINGS: Two osteoanabolic agents, abaloparatide and romosozumab, we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kostenuik, Paul J., Binkley, Neil, Anderson, Paul A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393898/ https://www.ncbi.nlm.nih.gov/pubmed/37289382 http://dx.doi.org/10.1007/s11914-023-00793-8

Ejemplares similares

Osteoanabolic Agents for Osteoporosis
por: Haas, Andrea V, et al.
Publicado: (2018)

Osteoanabolics
por: Gupta, Vishal, et al.
Publicado: (2012)

Effects of Extracellular Osteoanabolic Agents on the Endogenous Response of Osteoblastic Cells
por: Alloisio, Giulia, et al.
Publicado: (2021)

Relevance of Wnt signaling for osteoanabolic therapy
por: Yorgan, Timur A, et al.
Publicado: (2014)

Chondroitin sulfate-E mediates estrogen-induced osteoanabolism
por: Koike, Toshiyasu, et al.
Publicado: (2015)

Effects of osteoanabolic exercises on bone mineral density of osteoporotic females: A randomized controlled trial
por: Khan, Amna Aamir, et al.
Publicado: (2019)

Concerted Action of Androgens and Mechanical Strain Shifts Bone Metabolism from High Turnover into an Osteoanabolic Mode
por: Liegibel, Ute M., et al.
Publicado: (2002)

Progress in osteoporosis and fracture prevention: focus on postmenopausal women
por: Saag, Kenneth G, et al.
Publicado: (2009)

A Novel Osteoporosis Screening Protocol to Identify Orthopedic Surgery Patients for Preoperative Bone Health Optimization
por: Chang, Elliot, et al.
Publicado: (2022)

Effect of Bone Health Optimization on Osteoporosis Screening and Treatment Before Thoracolumbar Fusion
por: Bernatz, James T., et al.
Publicado: (2022)

Low acceptance of osteoanabolic therapy with parathyroid hormone in patients with fragility fracture of the pelvis in routine clinical practice: a retrospective observational cohort study
por: Suhm, Norbert, et al.
Publicado: (2019)

Fracture healing physiology and the quest for therapies for delayed healing and nonunion
por: Kostenuik, Paul, et al.
Publicado: (2016)

Fibroblast Growth Factor Receptor 3 Deficiency Does Not Impair the Osteoanabolic Action of Parathyroid Hormone on Mice
por: Xie, Yangli, et al.
Publicado: (2016)

Effects of systemically administered abaloparatide, an osteoanabolic PTHrP analog, as an adjuvant therapy for spinal fusion in rats
por: Arlt, Heike, et al.
Publicado: (2020)

A novel economic framework to assess the cost-effectiveness of bone-forming agents in the prevention of fractures in patients with osteoporosis
por: Söreskog, E., et al.
Publicado: (2021)

Telecarers improve osteoporosis treatment and compliance rates in secondary osteoporosis prevention for elderly hip fracture patients
por: Gani, Linsey Utami, et al.
Publicado: (2022)

Demethylbelamcandaquinone B (Dmcq B) Is the Active Compound of Marantodes pumilum var. alata (Blume) Kuntze with Osteoanabolic Activities
por: Ahmad Hairi, Haryati, et al.
Publicado: (2018)

Abaloparatide exhibits greater osteoanabolic response and higher cAMP stimulation and β‐arrestin recruitment than teriparatide
por: Sahbani, Karim, et al.
Publicado: (2019)

An evaluation of an enhanced fracture liaison service as the optimal model for secondary prevention of osteoporosis
por: Wallace, IR, et al.
Publicado: (2011)

Rates of Osteoporosis Management and Secondary Preventative Treatment After Primary Fragility Fractures
por: Ross, Bailey J., et al.
Publicado: (2021)

Focus on the agents most frequently responsible for perioperative anaphylaxis
por: Di Leo, E., et al.
Publicado: (2018)

Prevalence and Treatment of Osteoporosis Prior to Elective Shoulder Arthroplasty
por: Bernatz, James T., et al.
Publicado: (2020)

Secondary Osteoporosis and Metabolic Bone Diseases
por: Sobh, Mahmoud M., et al.
Publicado: (2022)

Proximal Femur Responses to Sequential Therapy With Abaloparatide Followed by Alendronate in Postmenopausal Women With Osteoporosis by 3D Modeling of Hip Dual‐Energy X‐Ray Absorptiometry (DXA)
por: Winzenrieth, Renaud, et al.
Publicado: (2022)

Secondary Prevention of Osteoporosis: If Not Now, When?
por: Dwolatzky, Tzvi
Publicado: (2022)

Recent Advances in the Genetics of Fractures in Osteoporosis
por: Koromani, Fjorda, et al.
Publicado: (2019)

Osteoprotegerin Reverses Osteoporosis by Inhibiting Endosteal Osteoclasts and Prevents Vascular Calcification by Blocking a Process Resembling Osteoclastogenesis
por: Min, Hosung, et al.
Publicado: (2000)

Secondary fracture prevention with osteoporosis medication after a fragility fracture in Sweden remains low despite new guidelines
por: Ek, Stina, et al.
Publicado: (2023)

Clinical practice guideline for management of osteoporosis and fracture prevention in Canada: 2023 update
por: Morin, Suzanne N., et al.
Publicado: (2023)

Effect of including historical height and radius BMD measurement on sarco-osteoporosis prevalence
por: Buehring, Bjoern, et al.
Publicado: (2012)

Advanced CT bone imaging in osteoporosis
por: Genant, H. K., et al.
Publicado: (2008)

Encouraging appropriate osteoporosis medication to prevent fracture
por: Tsai, Keh-Sung
Publicado: (2016)

Considerations for nasal bone fractures: Preoperative, perioperative, and postoperative
por: Han, Dong Gil
Publicado: (2020)

Environmental Air Pollution and the Risk of Osteoporosis and Bone Fractures
por: Nakao, Motoyuki, et al.
Publicado: (2018)

Environmental Air Pollution and the Risk of Osteoporosis and Bone Fractures
por: Nguyen, Vu H.
Publicado: (2018)

DXA parameters, Trabecular Bone Score (TBS) and Bone Mineral Density (BMD), in fracture risk prediction in endocrine-mediated secondary osteoporosis
por: Shevroja, Enisa, et al.
Publicado: (2021)

Advancement in the Treatment of Osteoporosis and the Effects on Bone Healing
por: Kushchayeva, Yevgeniya, et al.
Publicado: (2022)

Management of Age-Related Osteoporosis and Prevention of Associated Fractures
por: MacLaughlin, Eric J, et al.
Publicado: (2006)

Fracture prevention service to bridge the osteoporosis care gap
por: Ruggiero, Carmelinda, et al.
Publicado: (2015)

Putting the Brakes on Breaks: Osteoporosis Screening and Fracture Prevention
por: Goode, Sarah C., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hgkrf4d85hdvkocbo3ph6qq951